Teknova to Report Second Quarter 2022 Financial Results on August 10, 2022
HOLLISTER, Calif., Aug. 01, 2022 – Alpha Teknova, Inc. (Nasdaq: TKNO) announced it will report its financial results for Q2 2022 on August 10, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HOLLISTER, Calif., Aug. 01, 2022 – Alpha Teknova, Inc. (Nasdaq: TKNO) announced it will report its financial results for Q2 2022 on August 10, 2022, after market close. A conference call and webcast will follow at 4:30 p.m. ET. Teknova specializes in providing critical reagents for drug therapies, vaccines, and diagnostics, aiming to expedite clinical breakthroughs with a focus on custom solutions and fast delivery. Its products are essential across various applications, including cell and gene therapy and mRNA therapeutics.
Positive
- Upcoming Q2 2022 financial results reporting could provide insights into company performance.
- Teknova focuses on custom products and reagents which cater to both established and emerging applications.
Negative
- None.
Details
News Market Reaction – TKNO
The recorded move for TKNO in the trading session of this news was +14.37%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTER, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2022, on Wednesday, August 10, 2022, following the close of market.
Teknova will host a webcast and conference call on Wednesday, August 10, 2022, beginning at 4:30 p.m. ET. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/s88ivr8z. To receive a PIN number for dial in, participants can register for the webcast via this link: https://register.vevent.com/register/BI212f2574e2aa4cf68a5e40a4de877e89. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova is expediting clinical breakthroughs in life sciences by providing custom products and reagents for drug therapies, novel vaccines, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high-quality, custom, made-to-order products with short turnaround times and at scale across all stages of development, including commercialization.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.